|
Anxiety and Depression in Patients With Hematologic Malignancies
RECRUITINGSponsored by The First Affiliated Hospital of Xiamen University
Actively Recruiting
SponsorThe First Affiliated Hospital of Xiamen University
Started2026-10-20
Est. completion2030-12-01
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07883070
Summary
Assessment of Anxiety and Depression Status in Patients with Hematologic Malignancies
Eligibility
Healthy volunteers accepted
Inclusion Criteria: 1. Patients with hematologic malignancies who visit the Department of Hematology at the First Affiliated Hospital of Xiamen University from August 2026 onward, including lymphoma, multiple myeloma, and leukemia. 2. Patients who are able to understand and voluntarily participate in anxiety and depression status assessments. Exclusion Criteria: 1\. Patients with any other conditions considered by the investigator to be inappropriate for participation in this study.
Conditions4
AnxietyCancerDepressionHematologic Disease
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorThe First Affiliated Hospital of Xiamen University
Started2026-10-20
Est. completion2030-12-01
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07883070